Neuronal correlates in the modulation of placebo analgesia in experimentally-induced esophageal pain: A 3T-fMRI study

Pain

Volumn 148, Issue 1, 2010, Pages 75-83

  Lu, Hsueh Chieh ^a,b   Hsieh, Jen Chuen ^a,b   Lu, Ching Liang ^a,b   Niddam, David M ^a,b   Wu, Yu Te ^a,b   Yeh, Tzu Chen ^a,b   Cheng, Chou Ming ^b   Chang, Full Young ^a,b   Lee, Shou Dong ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

fMRI; Placebo; Visceral pain

Indexed keywords

ANALGESIC AGENT; PLACEBO;

ADULT; AMYGDALOID NUCLEUS; ANALGESIA; ANALGESIC ACTIVITY; ARTICLE; BRAIN FUNCTION; CINGULATE GYRUS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ESOPHAGUS PAIN; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; INSULA; MALE; MCGILL PAIN QUESTIONNAIRE; PAIN ASSESSMENT; PREFRONTAL CORTEX; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOMATOSENSORY CORTEX; THALAMUS; VISCERAL PAIN; VISUAL ANALOG SCALE;

ADULT; BALLOON DILATATION; BRAIN; BRAIN MAPPING; ESOPHAGUS; FEMALE; FUNCTIONAL LATERALITY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; OXYGEN; PAIN; PAIN MEASUREMENT; PLACEBO EFFECT; PLACEBOS; PSYCHOPHYSICS; YOUNG ADULT;

EID: 72149104585     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2009.10.012     Document Type: Article

References (49)

1. Allescher H.D., Bockenhoff A., Knapp G., Wienbeck M., and Hartung J. Treatment of non-ulcer dyspepsia: a meta-analysis of placebo-controlled prospective studies. Scand J Gastroenterol 36 (2001) 934-941
2. Belova M.A., Paton J.J., Morrison S.E., and Salzman C.D. Expectation modulates neural responses to pleasant and aversive stimuli in primate amygdala. Neuron 55 (2007) 970-984
3. Benedetti F., Mayberg H.S., Wager T.D., Stohler C.S., and Zubieta J.K. Neurobiological mechanisms of the placebo effect. J Neurosci 25 (2005) 10390-10402
4. Bingel U., Lorenz J., Schoell E., Weiller C., and Buchel C. Mechanisms of placebo analgesia: rACC recruitment of a subcortical antinociceptive network. Pain 120 (2006) 8-15
5. Chang M.Y., Chen C.H., and Huang K.F. A comparison of massage effects on labor pain using the McGill Pain Questionnaire. J Nurs Res 14 (2006) 190-197
6. Coen S.J., Yaguez L., Aziz Q., Mitterschiffthaler M.T., Brammer M., Williams S.C., and Gregory L.J. Negative mood affects brain processing of visceral sensation. Gastroenterology 137 (2009) 253-261 61e1-2
7. Dunckley P., Wise R.G., Aziz Q., Painter D., Brooks J., Tracey I., and Chang L. Cortical processing of visceral and somatic stimulation: differentiating pain intensity from unpleasantness. Neuroscience 133 (2005) 533-542
8. Dunckley P., Wise R.G., Fairhurst M., Hobden P., Aziz Q., Chang L., and Tracey I. A comparison of visceral and somatic pain processing in the human brainstem using functional magnetic resonance imaging. J Neurosci 25 (2005) 7333-7341
9. Eslick G.D., Jones M.P., and Talley N.J. Non-cardiac chest pain: prevalence, risk factors, impact and consulting - a population-based study. Aliment Pharmacol Ther 17 (2003) 1115-1124
10. Fox R.J., and Sorenson C.A. Bilateral lesions of the amygdala attenuate analgesia induced by diverse environmental challenges. Brain Res 648 (1994) 215-221
11. Hrobjartsson A., and Gotzsche P.C. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med 344 (2001) 1594-1602
12. Kern M., Hofmann C., Hyde J., and Shaker R. Characterization of the cerebral cortical representation of heartburn in GERD patients. Am J Physiol Gastrointest Liver Physiol 286 (2004) G174-G181
13. Kern M.K., Birn R.M., Jaradeh S., Jesmanowicz A., Cox R.W., Hyde J.S., and Shaker R. Identification and characterization of cerebral cortical response to esophageal mucosal acid exposure and distention. Gastroenterology 115 (1998) 1353-1362
14. Knight R.T., Grabowecky M.F., and Scabini D. Role of human prefrontal cortex in attention control. Adv Neurol 66 (1995) 21-34 [discussion 6]
15. Lieberman M.D., Jarcho J.M., Berman S., Naliboff B.D., Suyenobu B.Y., Mandelkern M., and Mayer E.A. The neural correlates of placebo effects: a disruption account. Neuroimage 22 (2004) 447-455
16. Locke III G.R., Talley N.J., Fett S.L., Zinsmeister A.R., and Melton III L.J. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 112 (1997) 1448-1456
17. Lu C.L., Wu Y.T., Yeh T.C., Chen L.F., Chang F.Y., Lee S.D., Ho L.T., and Hsieh J.C. Neuronal correlates of gastric pain induced by fundus distension: a 3T-fMRI study. Neurogastroenterol Motil 16 (2004) 575-587
18. Martin M.Y., Bradley L.A., Alexander R.W., Alarcon G.S., Triana-Alexander M., Aaron L.A., and Alberts K.R. Coping strategies predict disability in patients with primary fibromyalgia. Pain 68 (1996) 45-53
19. Matre D., Casey K.L., and Knardahl S. Placebo-induced changes in spinal cord pain processing. J Neurosci 26 (2006) 559-563
20. Mayberg H.S., Silva J.A., Brannan S.K., Tekell J.L., Mahurin R.K., McGinnis S., and Jerabek P.A. The functional neuroanatomy of the placebo effect. Am J Psychiatry 159 (2002) 728-737
21. McGaraughty S., and Heinricher M.M. Microinjection of morphine into various amygdaloid nuclei differentially affects nociceptive responsiveness and RVM neuronal activity. Pain 96 (2002) 153-162
22. Mearin F., Balboa A., Zarate N., Cucala M., and Malagelada J.R. Placebo in functional dyspepsia: symptomatic, gastrointestinal motor, and gastric sensorial responses. Am J Gastroenterol 94 (1999) 116-125
23. Mertz H., Morgan V., Tanner G., Pickens D., Price R., Shyr Y., and Kessler R. Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention. Gastroenterology 118 (2000) 842-848
24. Miller E.K., and Cohen J.D. An integrative theory of prefrontal cortex function. Annu Rev Neurosci 24 (2001) 167-202
25. Neugebauer V., Li W., Bird G.C., and Han J.S. The amygdala and persistent pain. Neuroscientist 10 (2004) 221-234
26. Pavlin D.J., Sullivan M.J., Freund P.R., and Roesen K. Catastrophizing: a risk factor for postsurgical pain. Clin J Pain 21 (2005) 83-90
27. Petrak F., Hardt J., Kappis B., Nickel R., and Tiber Egle U. Determinants of health-related quality of life in patients with persistent somatoform pain disorder. Eur J Pain 7 (2003) 463-471
28. Petrovic P., Dietrich T., Fransson P., Andersson J., Carlsson K., and Ingvar M. Placebo in emotional processing-induced expectations of anxiety relief activate a generalized modulatory network. Neuron 46 (2005) 957-969
29. Petrovic P., Kalso E., Petersson K.M., and Ingvar M. Placebo and opioid analgesia - imaging a shared neuronal network. Science 295 (2002) 1737-1740
30. Pitz M., Cheang M., and Bernstein C.N. Defining the predictors of the placebo response in irritable bowel syndrome. Clin Gastroenterol Hepatol 3 (2005) 237-247
31. Price D.D., Craggs J., Verne G.N., Perlstein W.M., and Robinson M.E. Placebo analgesia is accompanied by large reductions in pain-related brain activity in irritable bowel syndrome patients. Pain 127 (2007) 63-72
32. Price D.D., Craggs J.G., Zhou Q., Verne G.N., Perlstein W.M., and Robinson M.E. Widespread hyperalgesia in irritable bowel syndrome is dynamically maintained by tonic visceral impulse input and placebo/nocebo factors: evidence from human psychophysics, animal models, and neuroimaging. Neuroimage 47 (2009) 995-1001
33. Severeijns R., van den Hout M.A., Vlaeyen J.W., and Picavet H.S. Pain catastrophizing and general health status in a large Dutch community sample. Pain 99 (2002) 367-376
34. Strigo I.A., Bushnell M.C., Boivin M., and Duncan G.H. Psychophysical analysis of visceral and cutaneous pain in human subjects. Pain 97 (2002) 235-246
35. Strigo I.A., Duncan G.H., Boivin M., and Bushnell M.C. Differentiation of visceral and cutaneous pain in the human brain. J Neurophysiol 89 (2003) 3294-3303
36. Sullivan M.J., Lynch M.E., and Clark A.J. Dimensions of catastrophic thinking associated with pain experience and disability in patients with neuropathic pain conditions. Pain 113 (2005) 310-315
37. Sullivan M.J., Thorn B., Haythornthwaite J.A., Keefe F., Martin M., Bradley L.A., and Lefebvre J.C. Theoretical perspectives on the relation between catastrophizing and pain. Clin J Pain 17 (2001) 52-64
38. Tu C.H., Niddam D.M., Chao H.T., Liu R.S., Hwang R.J., Yeh T.C., and Hsieh J.C. Abnormal cerebral metabolism during menstrual pain in primary dysmenorrhea. Neuroimage 47 (2009) 28-35
39. Turner J.A., Jensen M.P., Warms C.A., and Cardenas D.D. Catastrophizing is associated with pain intensity, psychological distress, and pain-related disability among individuals with chronic pain after spinal cord injury. Pain 98 (2002) 127-134
40. Van Damme S., Crombez G., and Eccleston C. Disengagement from pain: the role of catastrophic thinking about pain. Pain 107 (2004) 70-76
41. Vandenberghe J., Dupont P., Van Oudenhove L., Bormans G., Demyttenaere K., Fischler B., Geeraerts B., Janssens J., and Tack J. Regional cerebral blood flow during gastric balloon distention in functional dyspepsia. Gastroenterology 132 (2007) 1684-1693
42. Vase L., Robinson M.E., Verne G.N., and Price D.D. Increased placebo analgesia over time in irritable bowel syndrome (IBS) patients is associated with desire and expectation but not endogenous opioid mechanisms. Pain 115 (2005) 338-347
43. Wager T.D., and Nitschke J.B. Placebo effects in the brain: linking mental and physiological processes. Brain Behav Immun 19 (2005) 281-282
44. Wager T.D., Rilling J.K., Smith E.E., Sokolik A., Casey K.L., Davidson R.J., Kosslyn S.M., Rose R.M., and Cohen J.D. Placebo-induced changes in FMRI in the anticipation and experience of pain. Science 303 (2004) 1162-1167
45. Watkins L.R., Wiertelak E.P., McGorry M., Martinez J., Schwartz B., Sisk D., and Maier S.F. Neurocircuitry of conditioned inhibition of analgesia: effects of amygdala, dorsal raphe, ventral medullary, and spinal cord lesions on antianalgesia in the rat. Behav Neurosci 112 (1998) 360-378
46. Woby S.R., Watson P.J., Roach N.K., and Urmston M. Adjustment to chronic low back pain - the relative influence of fear-avoidance beliefs, catastrophizing, and appraisals of control. Behav Res Ther 42 (2004) 761-774
47. Yap J.C., Lau J., Chen P.P., Gin T., Wong T., Chan I., Chu J., and Wong E. Validation of the Chinese Pain Catastrophizing Scale (HK-PCS) in patients with chronic pain. Pain Med 9 (2008) 186-195
48. Zhu W., and Pan Z.Z. Synaptic properties and postsynaptic opioid effects in rat central amygdala neurons. Neuroscience 127 (2004) 871-879
49. Zubieta J.K., Bueller J.A., Jackson L.R., Scott D.J., Xu Y., Koeppe R.A., Nichols T.E., and Stohler C.S. Placebo effects mediated by endogenous opioid activity on mu-opioid receptors. J Neurosci 25 (2005) 7754-7762